Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials

Background: We evaluated the time to progression (TTP) and survival outcomes of second-line therapy for metastatic colorectal cancer among adults aged 70 years and older compared with younger adults following progression on first-line clinical trials. Methods: Associations between clinical and disea...

ver descrição completa

Detalhes bibliográficos
Autor principal: McCleary, NJ (author)
Outros Autores: Harmsen, WS (author), Haakenstad, El (author), Cleary, JM (author), Meyerhardt, JA (author), Zalcberg, J (author), Adams, R (author), Grothey, A (author), Sobrero, AF (author), Van Cutsem, E (author), Goldberg, RM (author), Peeters, M (author), Tabernero, J (author), Seymour, M (author), Saltz, LB (author), Giantonio, BJ (author), Arnold, D (author), Rothenberg, ML (author), Koopman, M (author), Schmoll, HJ (author), Pitot, HC (author), Hoff, PM (author), Tebbutt, N (author), Masi, G (author), Souglakos, J (author), Bokemeyer, C (author), Heinemann, V (author), Yoshino, T (author), Chibaudel, B (author), deGramont, A (author), Shi, Q (author), Lichtman, SM (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Neoplasias do Colon
Neoplasias do Recto
Colonic Neoplasms
Rectal Neoplasms
Texto completo:https://doi.org/10.1093/jncics/pkac014
País:Portugal
Oai:oai:comum.rcaap.pt:10400.26/40841

Texto Completo

https://doi.org/10.1093/jncics/pkac014

Registos relacionados